Purchases and Sales Made in Q3 2024 in Centessa Pharmaceuticals PLC (CNTA)
This table provides information about the institutional ownership of Centessa Pharmaceuticals PLC (CNTA) during Q3 2024. The information is specifically focused on institutions that hold shares of Centessa Pharmaceuticals plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
35.9K+ 20.67% |
$308K - $610K
|
210K
$3.67M
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
32.9KNew |
$282K - $559K
|
32.9K
$577K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
27.9KNew |
$239K - $474K
|
27.9K
$489K
|
|
|
Nov 14, 2024
Q3 2024
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
24.7K+ 101.47% |
$212K - $420K
|
49.1K
$861K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
23.1K+ 68.75% |
$198K - $392K
|
56.6K
$992K
|
|
|
Nov 14, 2024
Q3 2024
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
20.1KNew |
$173K - $342K
|
20.1K
$353K
|
|
|
Nov 14, 2024
Q3 2024
|
Lynx1 Capital Management LP
San Juan, PR |
BUY
|
- |
17.4KNew |
$149K - $296K
|
17.4K
$305K
|
|
|
Oct 16, 2024
Q3 2024
|
Harbour Capital Advisors, LLC
|
BUY
|
- |
16.7KNew |
$143K - $283K
|
16.7K
$292K
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
13.1KNew |
$112K - $222K
|
13.1K
$229K
|
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
- |
12.9K+ 1047.72% |
$110K - $219K
|
14.1K
$247K
|
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
11.7KNew |
$101K - $199K
|
11.7K
$205K
|
|
|
Oct 25, 2024
Q3 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
6.79K+ 99.66% |
$58.2K - $115K
|
13.6K
$238K
|
|
|
Nov 13, 2024
Q3 2024
|
Entry Point Capital, LLC
New York, NY |
BUY
|
- |
5.52K+ 67.79% |
$47.3K - $93.7K
|
13.7K
$239K
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
5.16K+ 462.13% |
$44.3K - $87.7K
|
6.28K
$110K
|
|
|
Oct 15, 2024
Q3 2024
|
Advisors Preferred, LLC
Rockville, MD |
BUY
|
- |
4.56KNew |
$39.1K - $77.4K
|
4.56K
$79.8K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
2.2K+ 78.25% |
$18.9K - $37.3K
|
5.01K
$87.8K
|
|
|
Oct 29, 2024
Q3 2024
|
Golden State Equity Partners
South Coast Metro, CA |
BUY
|
- |
1.7KNew |
$14.6K - $28.9K
|
1.7K
$29.8K
|
|
|
Oct 04, 2024
Q3 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
1.51K+ 103.14% |
$12.9K - $25.6K
|
2.97K
$52.1K
|
|
|
Nov 01, 2024
Q3 2024
|
Atria Investments LLC
Charlotte, NC |
BUY
|
- |
1.12K+ 6.97% |
$9.58K - $19K
|
17.1K
$300K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
991+ 76.35% |
$8.5K - $16.8K
|
2.29K
$40.1K
|
|
|
Oct 23, 2024
Q3 2024
|
Mirae Asset Global Investments Co., Ltd.
|
BUY
|
- |
826+ 47.75% |
$7.09K - $14K
|
2.56K
$44.8K
|
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
- |
350New |
$3K - $5.95K
|
350
$6.14K
|
|
|
Oct 17, 2024
Q3 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
306+ 43.16% |
$2.63K - $5.2K
|
1.02K
$17.8K
|
|
|
Nov 14, 2024
Q3 2024
|
Virtus ETF Advisers LLC
New York, NY |
BUY
|
- |
169+ 1.85% |
$1.45K - $2.87K
|
9.29K
$163K
|
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
BUY
|
- |
108New |
$927 - $1.83K
|
108
$1.89K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 07, 2024
Q3 2024
|
Zurcher Kantonalbank (Zurich Cantonalbank)
Zurich, V8 |
SELL
|
- |
-35- 1.57% |
$300 - $595
|
2.2K
$38.5K
|
|
|
Nov 13, 2024
Q3 2024
|
Rathbones Group PLC
Liverpool, X0 |
SELL
|
- |
-900- 2.88% |
$7.72K - $15.3K
|
30.4K
$533K
|
|
|
Nov 14, 2024
Q3 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-2.53K- 2.06% |
$21.7K - $43K
|
120K
$2.11M
|
|
|
Nov 14, 2024
Q3 2024
|
Sandia Investment Management LP
Boston, MA |
SELL
|
- |
-5K- 50.0% |
$42.9K - $84.9K
|
5K
$87.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-6.21K- 37.91% |
$53.3K - $106K
|
10.2K
$178K
|
|
|
Nov 14, 2024
Q3 2024
|
Prelude Capital Management, LLC
New York, NY |
SELL
|
- |
-32K- 46.44% |
$275K - $544K
|
36.9K
$647K
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-44.1K- 19.6% |
$378K - $749K
|
181K
$3.17M
|
|
|
Nov 07, 2024
Q3 2024
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-66.2K- 13.35% |
$568K - $1.12M
|
430K
$7.53M
|
|
|
Nov 14, 2024
Q3 2024
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-137K- 49.74% |
$1.17M - $2.32M
|
138K
$2.42M
|
|
|
Nov 13, 2024
Q3 2024
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-170K- 14.98% |
$1.46M - $2.89M
|
966K
$16.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-230K- 90.8% |
$1.97M - $3.91M
|
23.3K
$408K
|
|
|
Nov 14, 2024
Q3 2024
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-333K- 14.2% |
$2.86M - $5.66M
|
2.01M
$35.3M
|
|
|
Nov 14, 2024
Q3 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-342K- 33.4% |
$2.93M - $5.81M
|
681K
$11.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-366K- 57.66% |
$3.14M - $6.23M
|
269K
$4.72M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-671K- 32.71% |
$5.75M - $11.4M
|
1.38M
$24.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-2.49M- 43.58% |
$21.4M - $42.3M
|
3.22M
$56.5M
|